Latest News - Partnerships

Monday, May 08, 2017 | Partnerships, Novaliq

Novaliq Conducts a First-in-Class Ocular Neuropathic Pain and Anti-Inflammatory Cannabinoid Drug Development Program in Collaboration with the University of Cologne

Novaliq announced successful application of a first-in-class ocular neuropathic pain and anti-inflammatory cannabinoid-based dry eye disease (DED) treatment approach in collaboration with the Universi…

Read the full story

Sunday, May 07, 2017 | Partnerships, Carl Zeiss Meditec

Zeiss Collaborates with the Advanced Retina Imaging Network to Advances Swept-Source OCT Technology

At this year’s ARVO (Association for Research in Vision and Ophthalmology) 2017 Annual Meeting, Zeiss is releasing a number of significant advancements to its PLEX Elite 9000 Swept-Source OCT an…

Read the full story

Saturday, May 06, 2017 | Partnerships, Product Releases, TearScience

CheckedUp and TearScience Team Up to Impact Dry Eye Patient Education

CheckedUp announced a nationwide partnership with TearScience, the maker of Lipiflow, to introduce the CheckedUp Engagement Platform to TearScience customers. The CheckedUp platform engages patients a…

Read the full story

Tuesday, May 02, 2017 | Partnerships, Imprimis Pharmaceuticals, SightLife Surgical

Imprimis Pharmaceuticals and SightLife Surgical Sign Agreement for National Launch of Serum Tears

Imprimis Pharmaceuticals announced the signing of an exclusive strategic sales and marketing agreement. Under the agreement, SightLife Surgical will deploy their sales team to offer Imprimis’ Se…

Read the full story

Monday, May 01, 2017 | Dry Eye, Partnerships, Parion Sciences, Shire

Shire and Parion Sciences Enter into a Collaborative License Agreement to Advance P-321 for Ophthalmic Indications

Shire and Parion Sciences announced they have entered into an agreement granting Shire exclusive worldwide rights to develop and commercialize P-321. Shire will lead development of P-321, an investi…

Read the full story

Friday, April 21, 2017 | Partnerships, Retina, ThromboGenics

Bicycle Therapeutics Announces a Candidate Preclinical Milestone in Its Ophthalmology Alliance with ThromboGenics

Bicycle Therapeutics announced the receipt of a preclinical milestone in connection with the advancement of a Bicycle into preclinical development for the treatment of diabetic macular edema, under it…

Read the full story

Wednesday, April 19, 2017 | Cataract Surgery, Partnerships, Carl Zeiss Meditec

First SMILE Laser Eye Surgery Procedures for US Navy Performed at Naval Medical Center San Diego

The first Zeiss ReLEx SMILE procedures for US Navy personnel were performed by Cmdr. John B. Cason, MD, Program Director, Navy Refractive Surgery Center San Diego. These procedures for the US Navy fol…

Read the full story

Wednesday, April 19, 2017 | Partnerships

H.I.G. Capital Makes a Strategic Investment in Barnet Dulaney Perkins and Southwestern Eye Center

H.I.G. Capital, a global private equity investment firm with $21 billion of equity capital under management, announced that one of its affiliates has made a strategic investment in Barnet Dulaney Perk…

Read the full story

Tuesday, April 18, 2017 | Partnerships, DigiSight Technologies

DigiSight Technologies Deploys Paxos Solution In Banner Health Emergency Departments

DigiSight Technologies announced that it has launched Paxos, a telehealth solution that enables health care teams to collaborate and make informed decisions at the point-of-care, at 13 Banner Health f…

Read the full story

Tuesday, April 18, 2017 | Partnerships, Imprimis Pharmaceuticals

Imprimis Pharmaceuticals and Precision Lens Sign Agreement to Expand Imprimis’ Ophthalmic Portfolio Market

Imprimis Pharmaceuticals and Cameron Ehlen Group, d/b/a Precision Lens, announced the signing of a 3-year exclusive sales representation agreement. Under the agreement, Precision Lens will deploy a de…

Read the full story

Wednesday, April 12, 2017 | Partnerships, Novartis

Commentary: Novartis Finds Its Next Mass-Market Ophthalmology Drug Candidate at a Small Virtual Biotech With a Global View

Like me, you may never have heard about Lubris BioPharma before today. But Novartis has. And that is by far more important. Today the pharma giant reached out and exercised an option on a recombinant …

Read the full story

Tuesday, April 04, 2017 | Partnerships, Paragon BioTeck 

Paragon Vision Sciences Announces Educational Partnerships with Leading Institutions and Organizations

Paragon Vision Sciences announced that it has entered into a series of educational partnership programs with several leading research institutions and organizations devoted to advancing eye care pract…

Read the full story

Friday, March 31, 2017 | Partnerships, Practice Development

Riata Capital Group Announces Formation of Acuity Eyecare

Riata Capital Group announced the formation of Acuity Eyecare Holdings, a company that will own and operate North American eyecare groups and optometry practices. Acuity launches with a strong platfor…

Read the full story

Friday, March 31, 2017 | Partnerships, Clearside Biomedical

Clearside Biomedical Enters into Strategic Collaboration with EyeKor to Support Clinical Development Efforts

Clearside Biomedical announced that it has entered into a strategic collaboration with EyeKor to support Clearside’s ophthalmic clinical trial activities. Clearside is currently conducting ph…

Read the full story

Thursday, March 30, 2017 | Partnerships, CooperVision

CooperVision Becomes First Major Contact Lens Manufacturer to Join The Vision Council

As part of its broad commitment to engaging and educating eye care professionals on clinical and marketplace advances, CooperVision announced today that it is the first major contact lens manufacturer…

Read the full story
Load More